This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2016
  • /
  • 11
  • /
  • CE Mark approval for Quadra Allure MP cardiac resy...
Drug news

CE Mark approval for Quadra Allure MP cardiac resynchronization therapy pacemaker (CRT-P) with magnetic resonance (MR) conditional labeling.- St Jude Medical

Read time: 1 mins
Last updated:9th Nov 2016
Published:9th Nov 2016
Source: Pharmawand

St.Jude Medical has announced CE Mark approval for magnetic resonance (MR) conditional labeling for the company�s Quadra Allure MP cardiac resynchronization therapy pacemaker (CRT-P). The Quadra Allure MP CRT-P, with its first-to-market MultiPoint Pacing technology, now offers patients the flexibility to undergo full-body diagnostic magnetic resonance imaging (MRI) scans of up to 1.5 Tesla (measurement for the strength of a magnetic field) for other conditions.

MultiPoint Pacing technology allows physicians the opportunity to capture more left ventricular tissue quickly by delivering pacing pulses to multiple left ventricle locations rather than the traditional single pulse for each heartbeat. Using the Quartet LV lead with its four uniquely spaced electrodes, physicians now have the capability to program two pulses from a single lead and tailor them to the specific needs of each patient.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.